BioSpace News Archive

Business

Voyager’s Al Sandrock, Alnylam’s Yvonne Greenstreet and More Share Their Predictions for 2023

BioSpace spoke with several leaders to gather their thoughts and predictions for the new year. Here is the first installment of this two-part series.

December 20, 2022
·
6 min read
·
Heather McKenzie
Business

Novartis’ Restructuring Claims 285 Jobs in New Jersey

Novartis will eliminate 285 jobs across units in New Jersey. The terminations will take effect on January 28, 2023.

December 20, 2022
·
2 min read
·
Tristan Manalac
Drug Development

FDA Places Clinical Hold on Entrada’s IND for Duchenne Muscular Dystrophy

The FDA placed a clinical hold on Entrada’s experimental DMD candidate.

December 20, 2022
·
2 min read
·
Alex Keown
Drug Development

Verona Pharma Eyes NDA for COPD Drug Based on Positive Phase III Data

Verona Pharma’s COPD candidate hits the mark in late-stage testing.

December 20, 2022
·
2 min read
·
Alex Keown
Drug Development

bluebird’s SCD Gene Therapy Released from Partial Hold

The FDA lifted its partial clinical hold on bluebird’s experimental sickle cell disease gene therapy for patients younger than 18.

December 20, 2022
·
2 min read
·
Tristan Manalac
Nykode announces expanded clinical development plan for its lead cancer vaccine VB10.16 in HPV16-positive cancers

Nykode Therapeutics ASA announced an expanded clinical development plan for VB10.16, the Company’s wholly-owned cancer vaccine, for the treatment of HPV16-positive cancers with high unmet need.

December 20, 2022
·
6 min read
Drug Development

REGiMMUNE Presented Positive Results of RGI-2001 in the Reduction of Acute GvHD from Phase 2b Study at the 2022 ASH Annual Meeting

REGiMMUNE Limited announced the positive results of their Phase 2b clinical trial for the prevention of acute graft-versus-host disease after allogeneic hematopoietic cell transplantation at the 2022 American Society of Hematology Annual Meeting.

December 20, 2022
·
4 min read
Genetown

Sosei Heptares to present at 41st Annual J.P. Morgan Healthcare Conference

Sosei Group Corporation announces its President & CEO Chris Cargill will present at the 41st Annual J.P. Morgan Healthcare Conference.

December 20, 2022
·
2 min read
Drug Development

Verona Pharma Announces Ensifentrine Meets Primary and Key Secondary Endpoints in Phase 3 ENHANCE-1 Trial for COPD

Verona Pharma plc, announces positive results of its Phase 3 ENHANCE-1 trial evaluating nebulized ensifentrine for the maintenance treatment of chronic obstructive pulmonary disease.

December 20, 2022
·
12 min read
Biotech Bay

Mainz Biomed Enrolls First Patient in eAArly DETECT Study Evaluating Integration of Novel mRNA Biomarkers into ColoAlert

Mainz Biomed NV announced the first patient has been enrolled in eAArly DETECT, Mainz’s U.S. extension of ColoFuture, its European feasibility study evaluating the integration of a portfolio of novel gene expression biomarkers into ColoAlert.

December 20, 2022
·
6 min read